Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • August 15 2012

    Arrowhead Research Corp. announced the closing of their Registered Direct offering in the amount of $6,240,000.  EG&S acted as counsel to the placement agent.

  • August 14 2012

    Generex Biotechnology Corporation announced the closing of their Registered Direct offering in the amount of $750,000.  EG&S acted as counsel to the Investor.

  • August 13 2012

    Eco Building Products, Inc. announced the closing of their PIPE offering in the amount of $1,080,000.  EG&S acted as counsel to the Investor.

  • August 08 2012

    ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $952,710.  EG&S acted as counsel to the placement agent.

  • August 07 2012

    pSivida Corp. announced the closing of their Registered Direct offering in the amount of $5,363,000. EG&S acted as counsel to the placement agent.

  • August 06 2012

    Stevia Corp. announced the closing of their PIPE offering in the amount of $500,000.  EG&S acted as counsel to the Investor.

  • July 31 2012

    NutraCea announced the closing of their PIPE offering in the amount of $290,000.  EG&S acted as counsel to the Investor.

  • July 26 2012

    Infinity Cross Border AcquisitionCorporation (Nasdaq: INXBU) announced the closing of their SPAC IPO in the amount of $40,000,000. EG&S acted as counsel to Infinity.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”